Drug Trial Radar · NCT05389696
Clinical Trial to Evaluate Pharmacokinetic Characteristics of MIT-001 After SC Administration in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Aug 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
May 13, 2022
Primary completion
Feb 13, 2023
Study completion Apr 28, 2023
Sponsor
- Lead sponsor
- MitoImmune TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- May 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
1. Part 1 Randimization, Double blinded, Placebo controlled, Dose escalation(10mg, 20mg, 40mg) of MIT-001 SC or IV single administration to evaluate safety, tolerability and PK in healthy adult. 2. Part2 Randimization, Double blinded, Placebo controlled, MIT-001 SC multiple administration for 7days (20mg \& 40mg) to evaluate safety, tolerability and PK in healthy adult.
Conditions
- Heathly Subjects
Interventions
Single subcutaneous administration and Blood collectionDrug
Single subcutaneous administration and Blood collection
Single subcutaneous administration and then IV injection.Drug
Single subcutaneous administration and then single intravenous administration after 2 weeks. In addition Blood collection is conducted as scheduled.
MIT-001 20mg and 40mg_Multiple administrationDrug
Multiple subcutaneous administration for 7 days and then blood collection
Primary outcomes
What the sponsor says the trial is designed to measure.
- PK_Cmax_Part1 Group 1&2Time frame: Part1. Group 1&2: Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
- PK_Cmax_Part1 Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
- PK_AUClast_Part1 Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
- PK_AUClast_Part1 Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
- PK_AUCinf_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
- PK_AUCinf_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
- PK_Tmax_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
- PK_Tmax_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
- PK_t1/2_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
- PK_t1/2_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
- PK_Vd/F_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
- PK_Vd/F_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
- PK_CL/F_Part 1, Group 1,2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
- PK_CL/F_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
- PK_MRT_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
- PK_MRT_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
- PK_F_Part1, Group1,2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
- PK_F_Part1, Group3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
- PK_Part2_CmaxTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_CminTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_CavgTime frame: Par2_Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_AUCtauTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_TmaxTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_t1/2Time frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_Vd/FTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_CL/FTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_Cmax,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_Cmin,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_Cavg,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_AUCtau,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_Tmax,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_t1/2,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_Vdss/FTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_CLss/FTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_PTFTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
- PK_Part2_RacTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seoul National University
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.